If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Each person's COPD symptoms and treatment options are different. You and your healthcare team ... Clinical trials are research studies that test how well new medical approaches work in people. Each ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

We need to provide these patients with life-saving options before their ... appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating ...

Here you'll find information, resources and tools to help you understand COPD, manage treatment and lifestyle changes, find support and take action. What you need to know about COPD Find out how COPD ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

A new, minimally invasive treatment available at The Ohio ... “Not only do we offer every available COPD treatment option including BLVR, but we also provide a variety of resources ranging from ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

these subjects with reduced time in the trial were driving the overall treatment effect of the IMPACT trial. To the best of our knowledge, this is the first study to explore causal inference models on ...